Skip to Main Content

Paper Details

Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
Pharmacoepidemiol Drug Saf
15
2018
Author NameAffiliation
Elizabeth A ChrischillesCollege of Public Health, University of Iowa
Joshua J GagneDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Jennifer C NelsonGroup Health Research Institute and Department of Biostatistics, University of Washington
Sengwee TohHarvard Medical School and Harvard Pilgrim Health Care Institute
Shirley V WangDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
Michael NguyenCenter for Drug Evaluation and Research
  • 1 - 6

Datasets